Mevopur™ Healthcare Colorants and Formulations Special Effect Colorants for Healthcare Devices and Pharmaceutical Packaging Self-administered medication, for example via pen devices and inhalers, has been the norm for many years. Ingredients used in the Mevopur™ portfolio have been tested to industry standards that support applications in both medical devices and pharmaceutical packaging.* KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified manufacturing sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal-derived substances • Available as pre-colored formulation or concentrate and for use in different polymers REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU** APPLICATION BULLETIN * Design note: Effect colors require careful consideration of part design and polymer flow paths to minimize visible flow lines.

Back Home // Products // Polymer Additives // Surface Modifier Additives // Cesa™ Low Retention Additives Non-PFAS formulations available Mevopur™ Healthcare Colorants and Formulations

Back Home // Products // Polymer Additives // Barrier and Scavenger Additives // ColorMatrix™ Amosorb™ 4020R rPET Booster Part of the ColorMatrix™ Amosorb™ range, Amosorb™ 4020R is an oxygen scavenging additive specifically formulated for use with recycled PET (rPET). Oxygen scavenger booster specifically formulated for use with recycled PET (rPET)

NYSE: POL), a leading global provider of specialized polymer materials, services and solutions, announced that its Board of Directors has elected The company's specialty journey continues to evolve and grow, and I am excited to be participating as a member of this diverse and talented Board." is a premier provider of specialized polymer materials, services and solutions.

NYSE: POL), a premier provider of specialized polymer materials, services and solutions, today announced that Walter has a broad understanding of our specialty technologies and their value-generating applications. is a premier provider of specialized polymer materials, services and solutions.

NYSE: POL), a premier provider of specialized polymer materials, services and solutions, today announced that as he helped to build our PP&S team and further refine the segment's strategy toward specialty.  is a premier provider of specialized polymer materials, services and solutions.

From product protection to aesthetics, we offer packaging customers one of the largest polymer-based solution and service portfolios available.” At the show, PolyOne will also feature a number of its specialty solutions, including a new aluminum cap liner technology, GLS™ Versaflex™ PKG 4190 thermoplastic elastomer (TPE). PolyOne Corporation, with 2014 revenues of $3.8 billion, is a premier provider of specialized polymer materials, services and solutions.

Explore how bio-polymers derived from sugarcane compare with petroleum-based TPEs. Developed in Asia based on our Dynalloy formulations. Recycled Nylon Formulations: Nymax™ REC

I N V E S T O R D A Y A G E N D A M A Y 1 0 , 2 0 1 8 PolyOne Corporation 5 8:00 WELCOME BREAKFAST 9:00 Introduction: Bob Patterson 9:45 Investing for Growth: Michael Garratt Commercial Resources Innovation Service 10:15 SEGMENT REVIEWS PolyOne Distribution: Scott Horn Specialty Engineered Materials: Michael Garratt BREAK (10 MINUTES) SEGMENT REVIEWS (CONTINUED) Performance Products & Solutions: Don Wiseman Color, Additives & Inks: Mark Crist 11:40 Mergers & Acquisitions: Joel Rathbun 12:00 Financial Review: Brad Richardson 12:20 Conclusion/Q&A: Bob Patterson 1:00 LUNCH Bradley C. Leverage PolyOne’s global reach Phase 1 Phase 2 Phase 3 18-20% operating margins Invest in commercial resources I N V E S T - T O - G R O W P R O O F O F P E R F O R M A N C E PolyOne Corporation 98 Commercial Operating Income Operating 243 335 $36 $90 Established Acquisitions (> 7 years) + 40% + 150% + 900 bps I N V E S T - T O - G R O W P R O O F O F P E R F O R M A N C E PolyOne Corporation 99 Commercial Operating Income (millions) 53 109 187 214 3 12 $12 $45 $22 $42 $2 Acquisition #1 (10 years) Acquisition #3 (7 years) Acquisition #2 (9 years) EBITDA Multiple 10.5x 3.0x 11.1x 7.6x 4.9x 2.8x 23% 17% 21% Return on Sales I N V E S T - T O - G R O W D R I V I N G T H E F U T U R E PolyOne Corporation 100 Commercial Operating Income Operating 44 65 $0 $0 0% 0% Advanced Composites I N V E S T - T O - G R O W D R I V I N G T H E F U T U R E PolyOne Corporation 101 Commercial Operating Income Operating 96 141 $16 $18 $36 11% 12% 18-20% Recent Color Acquisitions PolyOne Corporation 102 Average Company Size # of Possibilities Rationale 250 • Local to regional footprint • Niche technology focus • Concentrated customer base $50M–$200M 150 • Regional to global footprint • 1–3 specialty technologies • Diversified customer base >$200M 30 • Global footprint with local service • Diverse specialty technologies • Highly diversified customer & market portfolio S T R O N G P I P E L I N E D R I V E N B Y F R A G M E N T E D M A R K E T S U M M A R Y PolyOne Corporation 103 Proven track record with specialty acquisitions using invest-to-grow strategy Our approach to integration differentiates PolyOne in a competitive M&A market Trusted brand and reputation Buyer of choice Robust pipeline with a range of opportunities that fit our strategy FINANCIAL REVIEW B R A D R I C H A R D S O N PolyOne Corporation 104 PolyOne Corporation 105 A D J U S T E D E P S E X P A N S I O N 2009 2010 2011 2012 2013 2014 2015 2016* 2017* C O N S E C U T I V E Y E A R S $0.13 $0.68 $0.82 $1.00 $1.31 $1.80 $1.96 $2.06 $2.21 *Pro Forma for sale of DSS PolyOne Corporation 106 S T R A T E G I C C A S H D E P L O Y M E N T ORGANIC GROWTH Investing in R&D and capacity 11 Maintenance 40% Strategic Growth Investments 60% Capital Expenditures M&A OPPORTUNITIES Continued pursuit of strategic bolt on acquisitions that expand specialty offerings 2 SHAREHOLDER RETURN Dividends and share buybacks3 Over $400 million M&A Spending Since 2014 $809 million Share Repurchases 2011-Q1 2018 60% Increase in annual dividend over next three years 2011 2013 2015 2017 “Where we were” “Where we are” ROIC 5.0% 14.0% Operating Income % of Sales Color, Additives & Inks 1.7% 15.5% Specialty Engineered Materials 1.1% 12.1% Performance Products & Solutions 4.3% 10.7% Distribution 2.6% 6.3% P R O O F O F P E R F O R M A N C E E X P A N D I N G M A R G I N S & R O I C PolyOne Corporation 107 I N V E S T M E N T I N COMMERCIAL RESOURCES D R I V I N G R E S U L T S PolyOne Corporation 108 Largest organic revenue growth since recession $2.9 $2.9 $3.2 2015 2016 2017 Revenue in billions of $ Total + 10% Organic + 7% S U S T A I N A B L E P A T H T O D O U B L E - D I G I T E P S G R O W T H PolyOne Corporation 109 Double digit annual EPS growth Expand specialty portfolio with strategic acquisitions Innovate and develop new technologies and services Repurchase 600K-1M shares annually Increase commercial resources 6-8% annually Double acquired company margins Enhance efficiencies through Lean Six Sigma and commercial excellence R O I C D R I V E S S H A R E H O L D E R R E T U R N PolyOne Corporation 110 R O I C D R I V E S S H A R E H O L D E R R E T U R N PolyOne Corporation 111 $570 $1,650 $1,750 $2,000 ROIC Invested Capital Improving ROIC + Expanding Invested Capital = Outperforming the Market CONCLUSION B O B P A T T E R S O N PolyOne Corporation 112 1 Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to PolyOne shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to PolyOne shareholders, excluding special items, to assess performance and facilitate comparability of results. Investor Day Deck - Web Investor Day Forward �Looking �Statements Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: USE OF �NON-GAAP�MEASURES Investor Day Agenda May 10, 2018 The Leaders Behind the Team Introduction Historic Past Sustainability AT PolyOne Safety First the PolyOne Academy Sustainably Impacting diverse End Markets Products and Portfolio Optimization OUR PLANET Sustainability AT PolyOne Adjusted EPS Expansion Early years defined by Specialty �mix improvement Commodity Pruning �Held Organic Sales Flat Investment in Commercial Resources Driving Results Sustainable Path to Double-Digit EPS Growth Raising the Bar�ROIC drives shareholder return Commercial Excellence STRATEGIC INVESTMENT IN 3 KEY AREAS Key Commercial Investments New Resources Fueling the Future Aligning with trends for Growth Innovation 3 Horizons of Development 3 Horizons of Development 3 Horizons of Development Innovation Pipeline Innovation Drives Earnings Growth IQ DESIGN LABS 3D Printing�Bringing New ideas to life LSS CUSTOMER FIRST The Evolving Customer Relationship Slide Number 37 Inspired future Innovating with PolyOne PolyOne Distribution DISTRIBUTION Service is our business Service is our business Key Commercial Investments Growth through Inside Sales Growth through Multiple Sales Channels New Resources Fueling the Future Inspired future Specialty Engineered Materials Specialty Engineered Materials Specialty Engineered Materials Capitalizing on the global market STRATEGIC INVESTMENT IN 3 KEY AREAS Key Commercial Investments New Resources Fueling the Future growth Through Service Innovation Spotlight: Composites Composites Refresher Strategic Investment History COMPOSITES in Transportation Slide Number 61 Inspired future Performance Products �& Solutions Performance Products & Solutions Performance Products & Solutions STRATEGIC INVESTMENT IN 3 KEY AREAS Key Commercial Investments New Resources Fueling the Future Growth Through Service Growth Through Service Innovation Spotlight: �Flame Retardant�Polymers FLAME RETARDANT �DRIVERS Flame Retardant Performance Spectrum LED Solutions Inspired future Color Additives�& Inks COLOR, ADDITIVES & INKS Color, Additives & Inks Capitalizing on the global market STRATEGIC INVESTMENT IN 3 KEY AREAS Key Commercial Investments New Resources Fueling the Future Growth Through Service Innovation Spotlight: Additive & Colorant�Technologies Barrier Technologies Fiber Colorants Strategic Investment History Slide Number 88 Slide Number 89 COLORMATRIX SELECT™ Enabling the Customer Slide Number 92 Inspired future M&A Review Over a decade of successful specialty acquisitions Invest-to-Grow Strategy Invest-to-Grow Playbook Invest-to-Grow Proof of performance Invest-to-Grow Proof of performance Invest-to-Grow Driving the future Invest-to-Grow Driving the future Strong Pipeline�driven by fragmented Market Summary Financial Review Adjusted EPS Expansion Strategic cash deployment Proof of Performance �Expanding Margins & ROIC Investment in Commercial Resources Driving Results Sustainable Path to Double-Digit EPS Growth ROIC drives shareholder return ROIC drives shareholder return Conclusion Investor Presentation - May 2018 Non-GAAP Investor Presentation - March 2018

LABORATORY EQUIPMENT MANUFACTURER P C R W E L L P L A T E S • Very high level of TiO2 to prevent “cross-talk” between the wells during the qPCR fluorescence testing procedure • Minimized background phosphorescence caused by agglomeration of TiO2 and/or oxidized (stressed) polystyrene • Preservation of polystyrene grade properties • Change control of formulation and manufacturing process • Robust product quality from batch to batch • Developed optimally dispersed, ready-to-use white formulation that maintains adequate signal transmission, as well as minimizing “cross-talk” and background phosphorescence • Optimized the use of general purpose polystyrene (GPPS) for a good balance between melt flow and other physical properties, such as stiffness • Provided comprehensive change control of raw materials and formulation, with a robust manufacturing process and quality control under a third party ISO 13485:2016 certified QMS Mevopur Healthcare Colorants and Formulations – pre-colored solution WHY AVIENT? https://www.avient.com/products/polymer-colorants/healthcare-colorants/mevopur-healthcare-colorants-and-formulations Slide 1: laboratory equipment manufacturer